SMARCA2 ligand-13 PYR-Pip-spiro[3.3]heptane-acid
Selected Variant
HY-169490
Size: 1 Each
SMARCA2 ligand-13 PYR-Pip-spiro[3.3]heptane-acid is a conjugate generated by linking a target protein ligand to a linker (HY-169489). SMARCA2 ligand-13 PYR-Pip-spiro[3.3]heptane-acid can be used in the synthesis of PROTACs (e.g. PROTAC SMARCA2 degrader-21 (HY-169272) ).
Product Specifications
UNSPSC
12352005
Target
Target Protein Ligand-Linker Conjugates
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/target-protein-ligand-linker-conjugates-4.html
Smiles
O=C(O)C1CC2(CC(C2)N3CCC(CC3)C4=NC(N5CCN6C7=CC(C8=C(C=CC=C8)O)=NN=C7NC[C@H]6C5)=NC=C4)C1
Molecular Formula
C32H38N8O3
Molecular Weight
582.70
References & Citations
[1]Zhang Y, et al., Smarca degraders and uses thereof. WO2023278402. WIPO, 2022-06-28
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Transferrin (Early Marker of Oligodendrocytes) (TF/3001), CF594 conjugate, 0.1mg/mL
CD68 (C68/684 + KP1), CF740 conjugate, 0.1mg/mL
CD31 / PECAM-1 (JC/70A), Biotin conjugate, 0.1mg/mL
P53 Tumor Suppressor Protein (PAb1801), Biotin conjugate, 0.1mg/mL
